Supernus Pharmaceuticals (SUPN) Non-Current Assets (2011 - 2026)
Supernus Pharmaceuticals' Non-Current Assets was $704.61 million in Q2 2026, up 9.5% from $643.54 million a year earlier but down 8.4% from the prior quarter.
Powered by 
Analysis
Supernus Pharmaceuticals (SUPN) Non-Current Assets (2011 - 2026) Analysis & Trends
At the end of FY2025, Non-Current Assets at Supernus Pharmaceuticals came in at $808.47 million, up 18.5% from FY2024.
- Non-Current Assets shows a five-year compound annual growth rate of -1.5% (FY2020 to FY2025).
- In earlier years, Non-Current Assets was $682 million in FY2024 (-13.1%), $784.56 million in FY2023 (-19.0%), $968.36 million in FY2022 (-11.0%) and $1.09 billion in FY2021 (+24.5%).
- Quarterly Non-Current Assets has moved between $643.54 million (Q2 2025) and $1.09 billion (Q4 2021) over five years.
- Compared with a year earlier, Non-Current Assets has increased for four straight quarters, with growth averaging 1.1% over the last eight quarters.
- The best year-over-year quarter for Non-Current Assets over five years was Q4 2021 (growth of 24.5%); the worst was Q4 2023 (a decline of 19.0%).
- Per Business Quant data, SUPN's Non-Current Assets in the three quarters before Q2 2026 was $769.15 million (Q1 2026), $808.47 million (Q4 2025) and $825.86 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,138.33 Bn | 1,106.91 Bn | 19.71 Bn | 77.61 Bn |
| 2 | Johnson & Johnson | 618.82 Bn | 537.35 Bn | 17.26 Bn | 141.29 Bn |
| 3 | AbbVie | 503.36 Bn | 476.47 Bn | 12.70 Bn | 101.45 Bn |
| 4 | Merck | 369.59 Bn | 323.96 Bn | 12.21 Bn | 125.00 Mn |
| 5 | Novartis Ag | 298.57 Bn | 262.56 Bn | 11.24 Bn | 94.68 Bn |
| 6 | Astrazeneca | 261.25 Bn | 234.94 Bn | 12.86 Bn | 87.87 Bn |
| 7 | Amgen | 237.35 Bn | 192.75 Bn | 7.24 Bn | 60.68 Bn |
| 8 | Gilead Sciences | 191.27 Bn | 165.47 Bn | 6.22 Bn | 35.42 Bn |
| 9 | Pfizer | 170.03 Bn | 116.68 Bn | 10.94 Bn | 159.77 Bn |
| 10 | Supernus Pharmaceuticals | 2.38 Bn | 1.04 Bn | 185.39 Mn | 704.61 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 704.61 Mn |
| Mar 31, 2026 | 769.15 Mn |
| Dec 31, 2025 | 808.47 Mn |
| Sep 30, 2025 | 825.86 Mn |
| Jun 30, 2025 | 643.54 Mn |
| Mar 31, 2025 | 659.71 Mn |
| Dec 31, 2024 | 682.00 Mn |
| Sep 30, 2024 | 702.70 Mn |
| Jun 30, 2024 | 724.83 Mn |
| Mar 31, 2024 | 759.77 Mn |
| Dec 31, 2023 | 784.56 Mn |
| Sep 30, 2023 | 835.80 Mn |
| Jun 30, 2023 | 869.56 Mn |
| Mar 31, 2023 | 908.47 Mn |
| Dec 31, 2022 | 968.36 Mn |
| Sep 30, 2022 | 1.03 Bn |
| Jun 30, 2022 | 1.07 Bn |
| Mar 31, 2022 | 1.07 Bn |
| Dec 31, 2021 | 1.09 Bn |
| Sep 30, 2021 | 886.67 Mn |
API Access
Supernus Pharmaceuticals Non-Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-assets&ticker=SUPN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-assets", "ticker": "SUPN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-current-assets&ticker=SUPN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();